Update Aug 26': CTD-Comirnaty: New Disclosures of EMA's Embarrasing Redacted Re-Releases
Overriding public interest requires full transparency — EMA should clarify how independent validation is to be achieved with these redacted re-releases
This substack is devoted to make official releases from the European Medicines Agency (EMA), particularly regarding Covid vaccines, publicly available. It is a project by the Global Health Responsiblity Agency (GHRA) due to the EMAs inability to do so.
Live Last read · last published · next check
Overriding public interest requires full transparency — EMA should clarify how independent validation is to be achieved with these redacted re-releases
released on an ongoing basis by the European Medicines Agency as requested since 2023 by the PSUR4doctors initiative comprising 130 European doctors
Overriding public interest requires full transparency — EMA should clarify how independent validation is to be achieved with these redacted re-releases
Overriding public interest requires full transparency — EMA should clarify how independent validation is to be achieved with these redacted re-releases
Overriding public interest requires full transparency — EMA should clarify how independent validation is to be achieved with these redacted re-releases
Overriding public interest requires full transparency — EMA should clarify how independent validation is to be achieved with these redacted re-releases
released on an ongoing basis by the European Medicines Agency as requested since 2023 by the PSUR4doctors initiative comprising 130 European doctors
Overriding public interest requires full transparency — EMA should clarify how independent validation is to be achieved with these redacted re-releases
Overriding public interest requires full transparency — EMA should clarify how independent validation is to be achieved with these redacted re-releases
New EMA Releases about Safety Signals of PSUR#1